Artículos de revistas
Thrombomodulin Is Required For The Antithrombotic Activity Of Thrombin Mutant W215a/e217a In A Mouse Model Of Arterial Thrombosis.
Registro en:
Thrombosis Research. v. 130, n. 4, p. 646-8, 2012-Oct.
1879-2472
10.1016/j.thromres.2011.11.026
22178578
Autor
Vicente, Cristina P
Weiler, Hartmut
Di Cera, Enrico
Tollefsen, Douglas M
Institución
Resumen
The thrombin mutant W215A/E217A (WE thrombin) has greatly reduced procoagulant activity, but it activates protein C in the presence of thrombomodulin and inhibits binding of platelet glycoprotein Ib to von Willebrand factor and collagen under flow conditions. Both thrombomodulin-dependent protein C activation and inhibition of platelet adhesion could contribute to the antithrombotic activity of WE thrombin. To assess the role of thrombomodulin, we administered WE thrombin to thrombomodulin-deficient (TM(Pro/Pro)) mice and measured the time to occlusive thrombus formation in the carotid artery after photochemical injury of the endothelium. Doses of WE thrombin ≥10μg/kg prolonged the thrombosis time of wild-type mice (>1.6-fold), while doses ≥100μg/kg only slightly prolonged the thrombosis time of TM(Pro/Pro) mice. We conclude that thrombomodulin plays a predominate role in mediating the antithrombotic effect of WE thrombin in the arterial circulation of mice after endothelial injury. Thrombomodulin-independent effects may occur only when high doses of WE thrombin are administered. 130 646-8